AT EN
HOME > Press Releases
 

Authorize the processing of personal data
Edit email address
Invalid email
Email Sent
Authorize the processing of personal data

PRESS RELEASE

Chiesi Group and Aptar partner to bring to market Disease Management Platform for Patients with Asthma and COPD
18 October 2022
Chiesi is recertified as a B Corp and sets new tougher objectives for action by 2025
22 September 2022
Annual & Sustainability Report 2020
23 June 2021
Chiesi acts in response to Covid-19 pandemic
27 March 2020
Chiesi Group Announces Establishment of New Global Rare Diseases Division
06 February 2020
Chiesi Group and Apotex Inc. finalize agreement for acquisition of Ferriprox®
13 January 2020
© 2023 Chiesi Pharmaceuticals GmbH
Gonzagagasse 16/16 1010 Wien
Tel. +43.1.407 39 19 – 0
Fax +43.1.407 39 19 – 99019 oder 99999
Email: info.at@chiesi.com
CHIESI ON THE WEB